Turing Pharma close to replacing CEO Shkreli: WSJ
(Reuters) - Privately held drugmaker Turing Pharmaceuticals Inc is close to replacing Chief Executive Martin Shkreli, the Wall street Journal reported on Friday, a day after the FBI arrested him on charges of securities fraud.
Author: Regular Articles
Tell a friend
Average rating from Reviews:
Write a review